Neoplasms Metastasis Terminated Phase 2 Trials for motexafin gadolinium (DB05428)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00121420Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain MetastasesTreatment